CytomX TherapeuticsCTMX 
$1.07-1.83%24h
-1.83%24h
Global rank21445
Market cap$71.68M
Change 7d19.02%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of CytomX Therapeutics (CTMX)
As of January 2025, CytomX Therapeutics has a market cap of $71.68M. This makes CytomX Therapeutics the world's 21445th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of CytomX Therapeutics from 2015 to 2024
-
Value:-
Market cap history of CytomX Therapeutics from 2015 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $99.65M | -4.03% |
| 2023 | $103.83M | -3.13% |
| 2022 | $107.18M | -63.05% |
| 2021 | $290.06M | -33.89% |
| 2020 | $438.78M | -21.18% |
| 2019 | $556.68M | -44.97% |
| 2018 | $1.01B | -28.47% |
| 2017 | $1.41B | 92.08% |
| 2016 | $736.21M | -47.34% |
| 2015 | $1.40B | - |
CTMX Market Cap Today is $71.68M -1.83% - 1 Jan 2025
View largest stocks by market cap 
